Skip to main content

Colonoscopy News (Page 3)

>10 Percent of FIT Are Unsatisfactory and Cannot Be Processed

WEDNESDAY, Nov. 22, 2023 – More than 10 percent of fecal immunochemical tests (FIT) for colorectal cancer cannot be processed by a laboratory, and fewer than half complete a subsequent FIT within 15...

Risk-Adapted Starting Age of CRC Screening Varies by Sex, Genetics

MONDAY, Oct. 30, 2023 – Risk-adapted starting ages of screening vary by sex and polygenic risk score (PRS) among individuals at average risk for colorectal cancer (CRC), according to a study...

Most Folks Who Need Colon Cancer Screening Aren't Reminded by Doctors

TUESDAY, Sept. 12, 2023 – Many Americans are behind on recommended colon cancer screenings – and their doctors often fail to remind them, a new study suggests. The study, by the American Cancer...

Most Cancer Screens Won't Extend Lives, But Reasons to Keep Screening Remain

MONDAY, Aug. 28, 2023 – While new research suggests cancer screenings are not extending lives for the most part, the study's authors stressed that there are still good reasons why people should...

Risk Factors Identified for Early-Onset Sporadic Colorectal Cancer

MONDAY, July 3, 2023 – Risk factors for early-onset colorectal cancer (EOCRC) have been identified in a study published online June 6 in Cancer Prevention Research. Thomas F. Imperiale, M.D., from...

FDA Approves Suflave (polyethylene glycol 3350, sodium sulfate, potassium chloride, magnesium sulfate, and sodium chloride) Colonoscopy Preparation that Tastes Similar to a Sports Drink

BRAINTREE, Mass., June 22, 2023 /PRNewswire/ -- Sebela Pharmaceuticals today announced that the U.S. Food and Drug Administration (FDA) granted approval of Suflave™ (polyethylene glycol, sodium su...

FDA Approves Sutab (sodium sulfate, magnesium sulfate, and potassium chloride) Tablets for Colonoscopy Preparation

BRAINTREE, Mass., Nov. 10, 2020 /PRNewswire/ – Sebela Pharmaceuticals® today announces that the U.S. Food and Drug Administration (FDA) approved Sutab® (sodium sulfate, magnesium sulfate, and p...

Salix Receives FDA Approval for Plenvu, Next Generation 1-Liter Bowel Cleansing Preparation for Colonoscopies

BRIDGEWATER, N.J., May 7, 2018 /PRNewswire/ – Salix Pharmaceuticals, Ltd. ("Salix"), one of the largest specialty pharmaceutical companies in the world committed to the prevention and treatment of...

FDA Approves Clenpiq (sodium picosulfate, magnesium oxide, and anhydrous citric acid) Oral Solution for Colonoscopy Prep

Parsippany, NJ – November 29, 2017 – The U.S. Food and Drug Administration (FDA) has granted Ferring Pharmaceuticals Inc. approval to market Clenpiq (sodium picosulfate, magnesium oxide, and anh...

FDA Approves Prepopik for Colonoscopy Prep

July 17, 2012 - On July 16, the U.S. Food and Drug Administration approved Prepopik (sodium picosulfate, magnesium oxide and citric acid) to help cleanse the colon in adults preparing for...

Ask a question

To post your own question to this support group, sign in or create an account.